Diabetics, say goodbye to pre-meal shots
Posted 11.08.2005 at 3:00 am 0 Comments

phealthDiabetics_730.jpg

Daily insulin injections make it hard
for many diabetics to control blood sugar well enough to prevent serious complications like blindness and kidney failure. Now Pfizer and Sanofi-Aventis offer up the painless Exubera, an inhaler that delivers aerosolized insulin to the lungs, which quickly absorb the drug over their large surface area. A single puff just before meals can stabilize blood sugar as effectively as a shot. A Food and Drug Administration panel voted to approve Exubera this fall based on results from more than 52 clinical trials conducted over 10 years.

Want to learn more about breakthroughs in electronics, medicine, nanotech, and more?
Subscribe to Popular Science today, for less than $1 per issue!

0 Comments



June 2013: American Energy Independence

Five amazing, clean technologies that will set us free, in this month's energy-focused issue. Also: how to build a better bomb detector, the robotic toys that are raising your children, a human catapult, the world's smallest arcade, and much more.


Online Content Director: Suzanne LaBarre | Email
Senior Editor: Paul Adams | Email
Associate Editor: Dan Nosowitz | Email
Assistant Editor: Colin Lecher | Email
Assistant Editor: Rose Pastore | Email

Contributing Writers:

Kelsey D. Atherton | Email
Francie Diep | Email
Shaunacy Ferro | Email

circ-top-header.gif
circ-cover.gif